about
No increase in toxicity of pelvic irradiation when intensity modulation is employed: clinical and dosimetric data of 208 patients treated with post-prostatectomy radiotherapyContouring of the Pharyngeal Superior Constrictor Muscle (PSCM). A cooperative study of the Italian Association of Radiation Oncology (AIRO) Head and Neck Group.Hadrontherapy from the Italian Radiation Oncologist point of view: face the reality. The Italian Society of Oncological Radiotherapy (AIRO) survey.Primary focal prostate radiotherapy: Do all patients really need whole-prostate irradiation?Modeling the Interplay Between Tumor Volume Regression and Oxygenation in Uterine Cervical Cancer During Radiotherapy Treatment.Comparison between model-predicted tumor oxygenation dynamics and vascular-/flow-related Doppler indices.Kinetic Models for Predicting Cervical Cancer Response to Radiation Therapy on Individual Basis Using Tumor Regression Measured In Vivo With Volumetric Imaging.Role of interim 18F-FDG-PET/CT for the early prediction of clinical outcomes of Non-Small Cell Lung Cancer (NSCLC) during radiotherapy or chemo-radiotherapy. A systematic review.Phase II multi-institutional clinical trial on a new mixed beam RT scheme of IMRT on pelvis combined with a carbon ion boost for high-risk prostate cancer patients.Set-up errors in head and neck cancer patients treated with intensity modulated radiation therapy: Quantitative comparison between three-dimensional cone-beam CT and two-dimensional kilovoltage images.Voxel-based analysis unveils regional dose differences associated with radiation-induced morbidity in head and neck cancer patients.Dosimetric characterization of 3D printed bolus at different infill percentage for external photon beam radiotherapy.3D-printed applicators for high dose rate brachytherapy: Dosimetric assessment at different infill percentage.Evaluation of target coverage and margins adequacy during CyberKnife Lung Optimized Treatment.Interim 18F-FDG-PET/CT during chemo-radiotherapy in the management of oesophageal cancer patients. A systematic review.Multimodal image registration for the identification of dominant intraprostatic lesion in high-precision radiotherapy treatments.Stereotactic body radiation therapy for mediastinal lymph node metastases: how do we fly in a 'no-fly zone'?Nutritional Intervention for Nonsurgical Head and Neck Cancer Patients Treated with Radiation Therapy: Results from a Prospective Stepped-Wedge Clinical Protocol"Give me five" ultra-hypofractionated radiotherapy for localized prostate cancer: non-invasive ablative approachLate toxicity of image-guided hypofractionated radiotherapy for prostate: non-randomized comparison with conventional fractionationRe-irradiation for isolated local recurrence of prostate cancer: MONO-INSTITUTIONAL series of 64 patients treated with salvage stereotactic body radiotherapy (SBRT)Multi atlas based segmentation: should we prefer the best atlas group over the group of best atlases?Ablative stereotactic radiotherapy for oligometastatic colorectal cancer: Systematic reviewIntra- and inter-observer variability in breast tumour bed contouring and the controversial role of surgical clipsComparison of Outcomes and Toxicity Between Extreme and Moderate Radiation Therapy Hypofractionation in Localized Prostate Cancer: A Propensity Score AnalysisStereotactic radiation therapy in oligometastatic colorectal cancer: outcome of 102 patients and 150 lesionsImpact of image guidance on toxicity and tumour outcome in moderately hypofractionated external-beam radiotherapy for prostate cancer
P50
Q31083823-1DAE5EB2-609B-4820-BA78-3D1A1D44BAA0Q35203444-4716A834-E81E-495A-9BF6-202F7B9C58A5Q38807797-E5576441-5072-45B8-9768-63714E2B582BQ38891639-BD50E6E1-F40E-4421-B57D-134AA2C7BF88Q38913381-3CD857FD-5C9B-404C-B6D0-B89726391C53Q38920784-1FC7E9EA-E585-44AF-A291-DAFF77BC3632Q39030618-36977DE1-64E4-49D7-9455-3C9B6CF4DE2BQ39417217-FB56C610-3857-4FD7-BBF1-876263E3F7F8Q40410396-ECD180BA-F7FC-4AFE-A3EF-8F5656ACB61FQ41231390-2B47200A-172A-4381-839C-C1E45ED13336Q41244179-F6C94C6D-A9E5-4D67-968C-CAF8A2E4A4D1Q47764005-FA803272-91F1-4037-AF9C-4F084CB03E87Q48801318-AC60CAF1-E1F8-4C70-81A2-B74BD9448DCDQ50065344-013B5655-53A2-430C-AE21-18DA354388BCQ50065988-C4DA39AD-8C98-432D-883A-E92E2BD9D679Q52936169-FAA87753-C4C1-4A71-9CE2-B10EE3F490D3Q57032816-2C310B5E-7ADE-4488-A584-627966A30AAAQ57060690-0E094844-5142-4622-B314-6282CB9A897CQ57112876-F6EB9449-E1BD-45B7-AA2B-AB15F4598FD9Q57981842-2BD789F3-4E52-4E56-83AE-EAE72E9C36D3Q58086914-4F05C493-9607-42E3-975B-BA711DA0D972Q88771716-0A7978D3-4C8A-4BA6-B3B4-5387AA7BCB76Q90877398-6D8C8E6E-91F1-4388-AEE2-7454AA436EEBQ91628333-0DBB3C38-3EB4-4B14-B031-7A56C9619754Q92385971-CB436C59-C3E5-4849-BC25-D7E83B7C3728Q92529615-2AD5B094-D481-4D4E-8050-BD04425A49D4Q93358193-AC12C804-2C88-4448-B31C-049AEAC8B4BF
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Delia Ciardo
@ast
Delia Ciardo
@en
Delia Ciardo
@es
Delia Ciardo
@nl
type
label
Delia Ciardo
@ast
Delia Ciardo
@en
Delia Ciardo
@es
Delia Ciardo
@nl
prefLabel
Delia Ciardo
@ast
Delia Ciardo
@en
Delia Ciardo
@es
Delia Ciardo
@nl
P106
P21
P31
P496
0000-0001-6691-0208